Announced Mon, 9 Jun · 16:04 IST

Outcome of 271st Board meeting

Strategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Andrew Yule & Company Ltd's board, at its meeting on 9th June 2025, approved the sale of 3,48,480 equity shares of Veedol Corporation Ltd, representing 2% of Veedol's paid-up equity share capital. The sale will be carried out through an Offer for Sale (OFS) mechanism on the stock exchanges, in line with applicable regulations. The meeting lasted just 10 minutes (3:25 p.m. to 3:35 p.m.), suggesting a straightforward approval with prior deliberation. Andrew Yule continues to hold the balance of its Veedol stake after this transaction.

Likely market impact

This is a minor partial divestment of only 2% in Veedol, so the immediate financial impact on Andrew Yule is limited. Shareholders may view this as a portfolio rebalancing step rather than a strategic shift, with no major effect expected on the stock price.